Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beijing Chen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Organic Letters|February 3, 2025
Enantioselective Synthesis of Indole-Fused Polycycles Bearing Four Consecutive Stereocenters via Rhodium CatalysisTing Yu, Weiqi Liu, Beijing Chen, et al.
Frontiers in Psychiatry|January 10, 2022
Negative Emotions in Chinese Frontline Medical Staff During the Early Stage of the COVID-19 Epidemic: Status, Trend, and Influential Pathways Based on a National InvestigationXiaoxiao Sun, Fei Xie, Beijing Chen, et al.
Frontiers in Psychology|June 18, 2021
Fear in the Chinese Population: Influential Patterns in the Early Stage of the COVID-19 PandemicBeijing Chen, Xiaoxiao Sun, Fei Xie, et al.
Leukemia|March 26, 2026
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicityYutong Tu, Xiaojia Cai, Zhaofan Tao, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor ActivityBeijing Chen, Mingyang Sun, Chun Zhang, et al.
European Journal of Medicinal Chemistry|December 20, 2024
Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemiaBeijing Chen, Zhongyuan Wang, Qi Chen, et al.
Leukemia|December 16, 2022
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemiaKailong Jiang, Xuemei Li, Chang Wang, et al.
Journal of Medicinal Chemistry|June 24, 2024
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological TumorsHaiting Duan, Jingyu Zhang, Renzhao Gui, et al.
Journal of Medicinal Chemistry|February 12, 2025
Harnessing the Magic Methyl Effect: Discovery of CLPP-2068 as a Novel <i>Hs</i>ClpP Activator for the Treatment of Diffuse Large B-Cell LymphomaMingyang Sun, Beijing Chen, Dan Teng, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Organic Letters|February 3, 2025
Enantioselective Synthesis of Indole-Fused Polycycles Bearing Four Consecutive Stereocenters via Rhodium CatalysisTing Yu, Weiqi Liu, Beijing Chen, et al.
Frontiers in Psychiatry|January 10, 2022
Negative Emotions in Chinese Frontline Medical Staff During the Early Stage of the COVID-19 Epidemic: Status, Trend, and Influential Pathways Based on a National InvestigationXiaoxiao Sun, Fei Xie, Beijing Chen, et al.
Frontiers in Psychology|June 18, 2021
Fear in the Chinese Population: Influential Patterns in the Early Stage of the COVID-19 PandemicBeijing Chen, Xiaoxiao Sun, Fei Xie, et al.
Leukemia|March 26, 2026
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicityYutong Tu, Xiaojia Cai, Zhaofan Tao, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor ActivityBeijing Chen, Mingyang Sun, Chun Zhang, et al.
European Journal of Medicinal Chemistry|December 20, 2024
Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemiaBeijing Chen, Zhongyuan Wang, Qi Chen, et al.
Leukemia|December 16, 2022
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemiaKailong Jiang, Xuemei Li, Chang Wang, et al.
Journal of Medicinal Chemistry|June 24, 2024
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological TumorsHaiting Duan, Jingyu Zhang, Renzhao Gui, et al.
Journal of Medicinal Chemistry|February 12, 2025
Harnessing the Magic Methyl Effect: Discovery of CLPP-2068 as a Novel <i>Hs</i>ClpP Activator for the Treatment of Diffuse Large B-Cell LymphomaMingyang Sun, Beijing Chen, Dan Teng, et al.
Pageof 2